EMEA-000311-PIP04-13-M04
Key facts
Invented name |
Stelara
|
Active substance |
Ustekinumab
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/0083/2021
|
PIP number |
EMEA-000311-PIP04-13-M04
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of Crohn's disease
|
Route(s) of administration |
|
Contact for public enquiries |
Janssen Cilag International NV
Tel. +3214602111 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|